TRIM52 Plays an Oncogenic Role in Ovarian Cancer Associated with NF-kB Pathway

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2018 Sep 7

PMID 30185771

Citations 40

Authors

Weihong Yang

Li Liu

Caixia Li

Ning Luo

Rong Chen

Li Li

Fudong Yu

Zhongping Cheng

Affiliations

Soon will be listed here.

Abstract

Emerging evidence suggests that the members of the tripartite motif (TRIM) family play a crucial role in cancer development and progression. The purpose of the study was to explore TRIM52's role in tumorigenesis and its potential molecular mechanism in ovarian cancer. The study demonstrated that knockdown of TRIM52 in SKOV3 and CAOV3 cells inhibited ovarian cancer cell invasion, migration, and proliferation, and induced cell apoptosis. On the contrary, overexpression of TRIM52 in HO8910 cells showed contrary results. Further, overexpression of TRIM52 enhanced the expression of phosphorylated IKKβ and IKBα proteins and nuclear protein P65, which implied the activation of NF-kB signal pathway. Knockdown of TRIM52 downregulated the mRNA and protein levels of NF-kB signal downstream effectors of the NF-kB pathway, including MMP9, Bcl2, IL8, and TNFα, but upregulated caspase-3 expression. These results suggested that activation of the NF-kB pathway is involved in TRIM52-mediated regulation in ovarian cancer. The nude mice study further confirmed that knockdown of TRIM52 blocked tumor growth, inhibited cell proliferation, and promoted cell apoptosis. Our data strongly suggested that TRIM52 plays an oncogenic role in ovarian cancer development associated with the NF-kB signal pathway and may be a potential target for cancer therapy.

Citing Articles

Genomic characteristics and prognostic correlations in Chinese multiple myeloma patients.

Chen X, Luo T, Zhang W, Wang S, Zhu M, He H BMC Med Genomics. 2025; 18(1):50.

PMID: 40087669 DOI: 10.1186/s12920-025-02116-5.

The critical role of TRIM protein family in intervertebral disc degeneration: mechanistic insights and therapeutic perspectives.

Li S, Jiang W, Chen F, Qian J, Yang J Front Cell Dev Biol. 2025; 13:1525073.

PMID: 39981097 PMC: 11839679. DOI: 10.3389/fcell.2025.1525073.

Enhanced Expression of TRIM46 in Ovarian Cancer Cells Induced by Tumor-Associated Macrophages Promotes Invasion via the Wnt/β-Catenin Pathway.

Wang Y, Choi M, Kim J, Choi J Cells. 2025; 14(3).

PMID: 39937005 PMC: 11817100. DOI: 10.3390/cells14030214.

CSF3 promotes colorectal cancer progression by activating p65/NF-κB signaling pathway and inducing an immunosuppressive microenvironment.

Xu J, Li N, Xie H, Duan C, Liao X, Li R Transl Oncol. 2025; 53:102310.

PMID: 39929064 PMC: 11849657. DOI: 10.1016/j.tranon.2025.102310.

An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway.

Pandey P, Lakhanpal S, Mahmood D, Kang H, Kim B, Kang S Front Pharmacol. 2025; 15():1513422.

PMID: 39834817 PMC: 11743680. DOI: 10.3389/fphar.2024.1513422.

References

Li Q, Yan J, Mao A, Li C, Ran Y, Shu H . Tripartite motif 8 (TRIM8) modulates TNFα- and IL-1β-triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitination. Proc Natl Acad Sci U S A. 2011; 108(48):19341-6. PMC: 3228454. DOI: 10.1073/pnas.1110946108. View

Liu C, Huang X, Hou S, Hu B, Li H . Silencing of tripartite motif (TRIM) 29 inhibits proliferation and invasion and increases chemosensitivity to cisplatin in human lung squamous cancer NCI-H520 cells. Thorac Cancer. 2015; 6(1):31-7. PMC: 4448470. DOI: 10.1111/1759-7714.12130. View

Hayden M, Ghosh S . Regulation of NF-κB by TNF family cytokines. Semin Immunol. 2014; 26(3):253-66. PMC: 4156877. DOI: 10.1016/j.smim.2014.05.004. View

Luo N, Guo J, Chen L, Yang W, Qu X, Cheng Z . ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells. Cell Death Dis. 2016; 7:e2157. PMC: 4823924. DOI: 10.1038/cddis.2015.401. View

Zhu Z, Wang Y, Zhang C, Yu S, Zhu Q, Hou K . TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling. Sci Rep. 2016; 6:19070. PMC: 4709557. DOI: 10.1038/srep19070. View

Wu W, Xu Z, Hittelman W, Salomoni P, Pandolfi P, Chang K . Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway. J Biol Chem. 2003; 278(14):12294-304. DOI: 10.1074/jbc.M211849200. View

Meroni G, Diez-Roux G . TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays. 2005; 27(11):1147-57. DOI: 10.1002/bies.20304. View

Qiu F, Xiong J, Deng J, Xiang X . TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185. Int J Clin Exp Pathol. 2015; 8(5):5053-61. PMC: 4503071. View

Chae J, Wood G, Richard K, Jaffe H, Colburn N, Masters S . The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood. 2008; 112(5):1794-803. PMC: 2518886. DOI: 10.1182/blood-2008-01-134932. View

10.

Cheng Z, Guo J, Chen L, Luo N, Yang W, Qu X . Knockdown of EHF inhibited the proliferation, invasion and tumorigenesis of ovarian cancer cells. Mol Carcinog. 2015; 55(6):1048-59. DOI: 10.1002/mc.22349. View

11.

Luo Q, Lin H, Ye X, Huang J, Lu S, Xu L . Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway. Int J Clin Oncol. 2014; 20(3):508-17. DOI: 10.1007/s10147-014-0752-9. View

12.

Garraway L, Verweij J, Ballman K . Precision oncology: an overview. J Clin Oncol. 2013; 31(15):1803-5. DOI: 10.1200/JCO.2013.49.4799. View

13.

Hatakeyama S . TRIM proteins and cancer. Nat Rev Cancer. 2011; 11(11):792-804. DOI: 10.1038/nrc3139. View

14.

Allton K, Jain A, Herz H, Tsai W, Jung S, Qin J . Trim24 targets endogenous p53 for degradation. Proc Natl Acad Sci U S A. 2009; 106(28):11612-6. PMC: 2710642. DOI: 10.1073/pnas.0813177106. View

15.

Fan W, Liu T, Li X, Zhou Y, Wu M, Cui X . TRIM52: A nuclear TRIM protein that positively regulates the nuclear factor-kappa B signaling pathway. Mol Immunol. 2017; 82:114-122. DOI: 10.1016/j.molimm.2017.01.003. View

16.

Cheng Z, Guo J, Chen L, Luo N, Yang W, Qu X . Overexpression of TMEM158 contributes to ovarian carcinogenesis. J Exp Clin Cancer Res. 2015; 34:75. PMC: 4524016. DOI: 10.1186/s13046-015-0193-y. View

17.

Caratozzolo M, Micale L, Turturo M, Cornacchia S, Fusco C, Marzano F . TRIM8 modulates p53 activity to dictate cell cycle arrest. Cell Cycle. 2012; 11(3):511-23. DOI: 10.4161/cc.11.3.19008. View

18.

Egeblad M, Werb Z . New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2(3):161-74. DOI: 10.1038/nrc745. View

19.

Jones M, Kamara D, Karlan B, Pharoah P, Gayther S . Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction. Gynecol Oncol. 2017; 147(3):705-713. DOI: 10.1016/j.ygyno.2017.10.001. View

20.

Jin J, Hu H, Li H, Yu J, Xiao Y, Brittain G . Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity. Immunity. 2014; 40(3):342-54. PMC: 3983709. DOI: 10.1016/j.immuni.2014.02.006. View